India's pharmaceutical exports surge 9.67% to USD 27.9 billion in 2023-24, despite a 3% dip in total exports. March sees a 12.73% rise to USD 2.8 billion. US remains the top market, comprising over 31% of exports, followed by the UK and the Netherlands. Growing market opportunities expected to drive further growth.